XML 51 R36.htm IDEA: XBRL DOCUMENT v3.25.3
Equity (Tables)
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Net Income (Loss) Attributable to Common Stockholders and Transfers (to) from Noncontrolling Interests
The table below presents the effect on our equity from net income attributable to common stockholders and changes in our ownership interest in our Operating Partnership:
 Nine Months Ended September 30,
(In thousands)20252024
Net income attributable to common stockholders$23,111 $24,405 
Transfers from noncontrolling interests:
Exchange of OP Units with noncontrolling interests159 3,259 
Repurchases of OP Units from noncontrolling interests(16)— 
Net transfers from noncontrolling interests143 3,259 
Change from net income attributable to common stockholders and transfers from noncontrolling interests$23,254 $27,664 
Schedule of Accumulated Other Comprehensive Income (Loss)
The table below presents a reconciliation of our AOCI, which consists solely of adjustments related to derivatives designated as cash flow hedges:

Nine Months Ended September 30,
(In thousands)20252024
Accumulated Other Comprehensive Income - Beginning balance$54,917 $115,917 
Consolidated derivatives:
Other comprehensive (loss) income before reclassifications(8,304)22,399 
Reclassification of gains from AOCI to Interest Expense(47,985)(115,961)
Unconsolidated Fund's derivatives (our share)(2):
Other comprehensive income before reclassifications— 4,216 
Reclassification of gains from AOCI to Income from unconsolidated Fund— (2,798)
Consolidation of unconsolidated Fund(3)
(4,762)
Net current period OCI(61,051)(92,144)
OCI attributable to noncontrolling interests22,965 29,878 
OCI attributable to common stockholders(38,086)(62,266)
Accumulated Other Comprehensive Income - Ending balance$16,831 $53,651 
___________________________________________________
(1)See Note 10 for the details of our derivatives and Note 13 for our derivative fair value disclosures.
(2)We did not have any unconsolidated entities during the nine months ended September 30, 2025. For the comparable period, we calculate our share by multiplying the total amount for our Fund by our equity interest in the Fund. For more information about our Fund, including our equity interest percentage, see Note 6.
(3)We consolidated Partnership X commencing on January 1, 2025. Our share of the Partnership X's OCI on January 1, 2025 was reclassified to the gain from consolidation we recorded. See Note 3 regarding the consolidation of Partnership X.
Schedule of Stock-based Compensation Expense The table below presents our stock-based compensation expense:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2025202420252024
Stock-based compensation expense, net$2,386 $2,276 $7,525 $7,568 
Capitalized stock-based compensation$692 $678 $2,027 $1,976